 | • レポートコード：MRC23Q36281 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のポイントオブケア（POC）/迅速診断市場について調査・分析し、世界のポイントオブケア（POC）/迅速診断市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（迅速検査、分子診断）、用途別セグメント分析（病院、在宅医療）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Johnson and Johnson、Thermo Fisher Scientific、Bio-Techne、Roche Diagnostics、Siemens Healthineers、Abbott Laboratories、Danaher Corporation、BD、Sysmex、Cardinal Health、Quidel、GE Healthcare、EKF Diagnostics、bioMérieux SA、Accubiotech、PTS Diagnostics、Chembio Diagnostics、Trinity Biotech、Sekisui Diagnosticsなどが含まれています。世界のポイントオブケア（POC）/迅速診断市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、ポイントオブケア（POC）/迅速診断市場規模を推定する際に考慮しました。本レポートは、ポイントオブケア（POC）/迅速診断の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、ポイントオブケア（POC）/迅速診断に関するビジネス上の意思決定に役立てることを目的としています。 ・ポイントオブケア（POC）/迅速診断市場の概要 - ポイントオブケア（POC）/迅速診断のタイプ別セグメント - 世界のポイントオブケア（POC）/迅速診断市場規模：タイプ別分析（迅速検査、分子診断） - ポイントオブケア（POC）/迅速診断の用途別セグメント - 世界のポイントオブケア（POC）/迅速診断市場規模：用途別分析（病院、在宅医療） - 世界のポイントオブケア（POC）/迅速診断市場規模予測（2018年-2029年） ・ポイントオブケア（POC）/迅速診断市場の成長トレンド - ポイントオブケア（POC）/迅速診断の地域別市場規模（2018年-2029年） - ポイントオブケア（POC）/迅速診断市場ダイナミクス - ポイントオブケア（POC）/迅速診断の業界動向 - ポイントオブケア（POC）/迅速診断市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：迅速検査、分子診断 - 世界のポイントオブケア（POC）/迅速診断のタイプ別市場規模（2018年-2023年） - 世界のポイントオブケア（POC）/迅速診断のタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院、在宅医療 - 世界のポイントオブケア（POC）/迅速診断の用途別市場規模（2018年-2023年） - 世界のポイントオブケア（POC）/迅速診断の用途別市場規模（2024年-2029年） ・ポイントオブケア（POC）/迅速診断の地域別市場規模 - 北米のポイントオブケア（POC）/迅速診断市場規模（2018年-2029年） - アメリカのポイントオブケア（POC）/迅速診断市場規模（2018年-2029年） - ヨーロッパのポイントオブケア（POC）/迅速診断市場規模（2018年-2029年） - アジア太平洋のポイントオブケア（POC）/迅速診断市場規模（2018年-2029年） - 中国のポイントオブケア（POC）/迅速診断市場規模（2018年-2029年） - 日本のポイントオブケア（POC）/迅速診断市場規模（2018年-2029年） - 韓国のポイントオブケア（POC）/迅速診断市場規模（2018年-2029年） - インドのポイントオブケア（POC）/迅速診断市場規模（2018年-2029年） - オーストラリアのポイントオブケア（POC）/迅速診断市場規模（2018年-2029年） - 中南米のポイントオブケア（POC）/迅速診断市場規模（2018年-2029年） - 中東・アフリカのポイントオブケア（POC）/迅速診断市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Johnson and Johnson、Thermo Fisher Scientific、Bio-Techne、Roche Diagnostics、Siemens Healthineers、Abbott Laboratories、Danaher Corporation、BD、Sysmex、Cardinal Health、Quidel、GE Healthcare、EKF Diagnostics、bioMérieux SA、Accubiotech、PTS Diagnostics、Chembio Diagnostics、Trinity Biotech、Sekisui Diagnostics ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Point of Care & Rapid Diagnostics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Point of Care & Rapid Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Point of Care & Rapid Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Point of Care & Rapid Diagnostics in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Point of Care & Rapid Diagnostics include Johnson and Johnson, Thermo Fisher Scientific, Bio-Techne, Roche Diagnostics, Siemens Healthineers, Abbott Laboratories, Danaher Corporation, BD and Sysmex, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Point of Care & Rapid Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point of Care & Rapid Diagnostics.
The Point of Care & Rapid Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Point of Care & Rapid Diagnostics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Point of Care & Rapid Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Johnson and Johnson
Thermo Fisher Scientific
Bio-Techne
Roche Diagnostics
Siemens Healthineers
Abbott Laboratories
Danaher Corporation
BD
Sysmex
Cardinal Health
Quidel
GE Healthcare
EKF Diagnostics
bioMérieux SA
Accubiotech
PTS Diagnostics
Chembio Diagnostics
Trinity Biotech
Sekisui Diagnostics
Segment by Type
Rapid Test
Molecular Diagnostics
Segment by Application
Hospital
Home Care
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Point of Care & Rapid Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point of Care & Rapid Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Rapid Test
1.2.3 Molecular Diagnostics
1.3 Market by Application
1.3.1 Global Point of Care & Rapid Diagnostics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Home Care
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Point of Care & Rapid Diagnostics Market Perspective (2018-2029)
2.2 Point of Care & Rapid Diagnostics Growth Trends by Region
2.2.1 Global Point of Care & Rapid Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Point of Care & Rapid Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Point of Care & Rapid Diagnostics Forecasted Market Size by Region (2024-2029)
2.3 Point of Care & Rapid Diagnostics Market Dynamics
2.3.1 Point of Care & Rapid Diagnostics Industry Trends
2.3.2 Point of Care & Rapid Diagnostics Market Drivers
2.3.3 Point of Care & Rapid Diagnostics Market Challenges
2.3.4 Point of Care & Rapid Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point of Care & Rapid Diagnostics Players by Revenue
3.1.1 Global Top Point of Care & Rapid Diagnostics Players by Revenue (2018-2023)
3.1.2 Global Point of Care & Rapid Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Point of Care & Rapid Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Point of Care & Rapid Diagnostics Revenue
3.4 Global Point of Care & Rapid Diagnostics Market Concentration Ratio
3.4.1 Global Point of Care & Rapid Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point of Care & Rapid Diagnostics Revenue in 2022
3.5 Point of Care & Rapid Diagnostics Key Players Head office and Area Served
3.6 Key Players Point of Care & Rapid Diagnostics Product Solution and Service
3.7 Date of Enter into Point of Care & Rapid Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Point of Care & Rapid Diagnostics Breakdown Data by Type
4.1 Global Point of Care & Rapid Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Point of Care & Rapid Diagnostics Forecasted Market Size by Type (2024-2029)
5 Point of Care & Rapid Diagnostics Breakdown Data by Application
5.1 Global Point of Care & Rapid Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Point of Care & Rapid Diagnostics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Point of Care & Rapid Diagnostics Market Size (2018-2029)
6.2 North America Point of Care & Rapid Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Point of Care & Rapid Diagnostics Market Size by Country (2018-2023)
6.4 North America Point of Care & Rapid Diagnostics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Point of Care & Rapid Diagnostics Market Size (2018-2029)
7.2 Europe Point of Care & Rapid Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Point of Care & Rapid Diagnostics Market Size by Country (2018-2023)
7.4 Europe Point of Care & Rapid Diagnostics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Point of Care & Rapid Diagnostics Market Size (2018-2029)
8.2 Asia-Pacific Point of Care & Rapid Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Point of Care & Rapid Diagnostics Market Size by Region (2018-2023)
8.4 Asia-Pacific Point of Care & Rapid Diagnostics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Point of Care & Rapid Diagnostics Market Size (2018-2029)
9.2 Latin America Point of Care & Rapid Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Point of Care & Rapid Diagnostics Market Size by Country (2018-2023)
9.4 Latin America Point of Care & Rapid Diagnostics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point of Care & Rapid Diagnostics Market Size (2018-2029)
10.2 Middle East & Africa Point of Care & Rapid Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Point of Care & Rapid Diagnostics Market Size by Country (2018-2023)
10.4 Middle East & Africa Point of Care & Rapid Diagnostics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson and Johnson
11.1.1 Johnson and Johnson Company Detail
11.1.2 Johnson and Johnson Business Overview
11.1.3 Johnson and Johnson Point of Care & Rapid Diagnostics Introduction
11.1.4 Johnson and Johnson Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.1.5 Johnson and Johnson Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Point of Care & Rapid Diagnostics Introduction
11.2.4 Thermo Fisher Scientific Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Bio-Techne
11.3.1 Bio-Techne Company Detail
11.3.2 Bio-Techne Business Overview
11.3.3 Bio-Techne Point of Care & Rapid Diagnostics Introduction
11.3.4 Bio-Techne Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.3.5 Bio-Techne Recent Development
11.4 Roche Diagnostics
11.4.1 Roche Diagnostics Company Detail
11.4.2 Roche Diagnostics Business Overview
11.4.3 Roche Diagnostics Point of Care & Rapid Diagnostics Introduction
11.4.4 Roche Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.4.5 Roche Diagnostics Recent Development
11.5 Siemens Healthineers
11.5.1 Siemens Healthineers Company Detail
11.5.2 Siemens Healthineers Business Overview
11.5.3 Siemens Healthineers Point of Care & Rapid Diagnostics Introduction
11.5.4 Siemens Healthineers Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.5.5 Siemens Healthineers Recent Development
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Company Detail
11.6.2 Abbott Laboratories Business Overview
11.6.3 Abbott Laboratories Point of Care & Rapid Diagnostics Introduction
11.6.4 Abbott Laboratories Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.6.5 Abbott Laboratories Recent Development
11.7 Danaher Corporation
11.7.1 Danaher Corporation Company Detail
11.7.2 Danaher Corporation Business Overview
11.7.3 Danaher Corporation Point of Care & Rapid Diagnostics Introduction
11.7.4 Danaher Corporation Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.7.5 Danaher Corporation Recent Development
11.8 BD
11.8.1 BD Company Detail
11.8.2 BD Business Overview
11.8.3 BD Point of Care & Rapid Diagnostics Introduction
11.8.4 BD Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.8.5 BD Recent Development
11.9 Sysmex
11.9.1 Sysmex Company Detail
11.9.2 Sysmex Business Overview
11.9.3 Sysmex Point of Care & Rapid Diagnostics Introduction
11.9.4 Sysmex Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.9.5 Sysmex Recent Development
11.10 Cardinal Health
11.10.1 Cardinal Health Company Detail
11.10.2 Cardinal Health Business Overview
11.10.3 Cardinal Health Point of Care & Rapid Diagnostics Introduction
11.10.4 Cardinal Health Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.10.5 Cardinal Health Recent Development
11.11 Quidel
11.11.1 Quidel Company Detail
11.11.2 Quidel Business Overview
11.11.3 Quidel Point of Care & Rapid Diagnostics Introduction
11.11.4 Quidel Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.11.5 Quidel Recent Development
11.12 GE Healthcare
11.12.1 GE Healthcare Company Detail
11.12.2 GE Healthcare Business Overview
11.12.3 GE Healthcare Point of Care & Rapid Diagnostics Introduction
11.12.4 GE Healthcare Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.12.5 GE Healthcare Recent Development
11.13 EKF Diagnostics
11.13.1 EKF Diagnostics Company Detail
11.13.2 EKF Diagnostics Business Overview
11.13.3 EKF Diagnostics Point of Care & Rapid Diagnostics Introduction
11.13.4 EKF Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.13.5 EKF Diagnostics Recent Development
11.14 bioMérieux SA
11.14.1 bioMérieux SA Company Detail
11.14.2 bioMérieux SA Business Overview
11.14.3 bioMérieux SA Point of Care & Rapid Diagnostics Introduction
11.14.4 bioMérieux SA Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.14.5 bioMérieux SA Recent Development
11.15 Accubiotech
11.15.1 Accubiotech Company Detail
11.15.2 Accubiotech Business Overview
11.15.3 Accubiotech Point of Care & Rapid Diagnostics Introduction
11.15.4 Accubiotech Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.15.5 Accubiotech Recent Development
11.16 PTS Diagnostics
11.16.1 PTS Diagnostics Company Detail
11.16.2 PTS Diagnostics Business Overview
11.16.3 PTS Diagnostics Point of Care & Rapid Diagnostics Introduction
11.16.4 PTS Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.16.5 PTS Diagnostics Recent Development
11.17 Chembio Diagnostics
11.17.1 Chembio Diagnostics Company Detail
11.17.2 Chembio Diagnostics Business Overview
11.17.3 Chembio Diagnostics Point of Care & Rapid Diagnostics Introduction
11.17.4 Chembio Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.17.5 Chembio Diagnostics Recent Development
11.18 Trinity Biotech
11.18.1 Trinity Biotech Company Detail
11.18.2 Trinity Biotech Business Overview
11.18.3 Trinity Biotech Point of Care & Rapid Diagnostics Introduction
11.18.4 Trinity Biotech Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.18.5 Trinity Biotech Recent Development
11.19 Sekisui Diagnostics
11.19.1 Sekisui Diagnostics Company Detail
11.19.2 Sekisui Diagnostics Business Overview
11.19.3 Sekisui Diagnostics Point of Care & Rapid Diagnostics Introduction
11.19.4 Sekisui Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.19.5 Sekisui Diagnostics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details